Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 6.7575 USD -0.18% Market Closed
Market Cap: 513.1m USD
Have any thoughts about
Chromadex Corp?
Write Note

Chromadex Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chromadex Corp
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Cost of Revenue
-$35.3m
CAGR 3-Years
-12%
CAGR 5-Years
-13%
CAGR 10-Years
-15%
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$8.6B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-10%

See Also

What is Chromadex Corp's Cost of Revenue?
Cost of Revenue
-35.3m USD

Based on the financial report for Sep 30, 2024, Chromadex Corp's Cost of Revenue amounts to -35.3m USD.

What is Chromadex Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-15%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Chromadex Corp have been -12% over the past three years , -13% over the past five years , and -15% over the past ten years .

Back to Top